chomp chomp chomp, page-44

IMO, its most likely 2b a cashed up superfund manager. Just taking a smart guess. Why, u may ask?

In that report that Istari posted earlier today, there was a mention of a Link Fund(?) buying more shares in June/July. I've read & heard Kinetic Investments analyst, Lez W, who's been very bullish on FNArena & has recommended PRR to his clients since its 7 cent days, so wouldnt b surprised that its starting to get noticed as a small-cap stk with potential.

If u really want to see a success curve in recent times, do chk out ACR (Acrux). They got their Phase-3 trial results successfully, about 7 days back & their SP has been consistently creeping up since their early product trial days. Thats the sort of story PRR could go on to, in the future if it meets all internal hurdles, IMO.

Given that their SP was lingering at 7c few months back, it's currently up apprx. 3 times (20c).

IMO, fund managers can always take huge chunks & lock them in for the longhaul, all part of their investment strategy, just in case PRR turns out 2b as good as the Gardasil story.

As for PRR, their is a lot of upside, if their Phase IIb & other results come in as expected, it may not stay as a 20c stk, hence the unusual big chunk buys.